Gilead Sciences Inc
(BUE:GILD)
ARS
25950
-75 (-0.29%)
Market Cap: 105.89 Til
Enterprise Value: 126.07 Til
PE Ratio: 105.76
PB Ratio: 5.91
GF Score: 55/100 - Q2 2024 Gilead Sciences Inc Earnings Call TranscriptAug 08, 2024ARS24700 (+0.30%)Earnings
- Q1 2024 Gilead Sciences Inc Earnings Call TranscriptApr 25, 2024ARS17628 (+0.04%)Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2024
- Gilead Sciences Inc at Leerink Partners Global Biopharma Conference TranscriptMar 12, 2024
- Gilead Sciences Inc at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Gilead Sciences Inc Earnings Call TranscriptFeb 06, 2024ARS24305.5 (-1.57%)Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Gilead Sciences Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Gilead Sciences Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2023
- Q3 2023 Gilead Sciences Inc Earnings Call TranscriptNov 07, 2023ARS17384.5 (-3.39%)Earnings
- Assembly Biosciences Inc Partnership with Gilead Sciences Inc to Develop Next-Generation Antiviral Therapeutics Call TranscriptOct 17, 2023
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Gilead Sciences Inc at Wells Fargo Healthcare Conference TranscriptSep 06, 2023
- Q2 2023 Gilead Sciences Inc Earnings Call TranscriptAug 03, 2023ARS10887 (+1.59%)Earnings
- Gilead Sciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Gilead Sciences Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Gilead Sciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Gilead Sciences Inc Earnings Call TranscriptApr 27, 2023ARS9511.5 (-2.97%)Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Gilead Sciences Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Gilead Sciences Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Q4 2022 Gilead Sciences Inc Earnings Call TranscriptFeb 02, 2023ARS7415 (-3.80%)Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Gilead Sciences Inc and Arcus Biosciences Inc Post ARC-7 Plenary Q&A TranscriptDec 20, 2022
- Gilead Sciences Inc at Nasdaq Investor Conference TranscriptDec 07, 2022
- Gilead Sciences Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Gilead Sciences Inc Earnings Call TranscriptOct 27, 2022ARS5413.5 (+0.16%)Earnings
- Gilead Sciences Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Gilead Sciences Inc at Wells Fargo Healthcare Conference TranscriptSep 08, 2022
- Q2 2022 Gilead Sciences Inc Earnings Call TranscriptAug 02, 2022ARS4279.5 (+1.95%)Earnings
- Gilead Sciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Gilead Sciences Inc at Sanford C Bernstein Strategic Decisions Conference TranscriptJun 02, 2022
- Gilead Sciences Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Gilead Sciences Inc Earnings Call TranscriptApr 28, 2022ARS3148 (-2.39%)Earnings
- Gilead Sciences Inc Oncology Deep Dive TranscriptApr 14, 2022
- Gilead Sciences Inc at Cowen Health Care Conference (Virtual) TranscriptMar 09, 2022
- Gilead Sciences Inc at Raymond James Institutional Investors Conference TranscriptMar 08, 2022
- Gilead Sciences Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 16, 2022
- Q4 2021 Gilead Sciences Inc Earnings Call TranscriptFeb 01, 2022ARS3795 (-0.14%)Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Gilead Sciences Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 02, 2021
- Arcus Biosciences to Discuss the Expanded Partnership with Gilead Sciences Inc- Conference Call TranscriptNov 18, 2021
- Q3 2021 Gilead Sciences Inc Earnings Call TranscriptOct 28, 2021ARS3469 (+3.01%)Earnings
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Gilead Sciences Inc Earnings Call TranscriptJul 29, 2021ARS3160Earnings
- Gilead Sciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Gilead Sciences Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptJun 02, 2021
- Gilead Sciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Gilead Sciences Inc at Cowen Virtual Oncology Innovation Summit TranscriptMay 21, 2021
- Gilead Sciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Gilead Sciences Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 Gilead Sciences Inc Earnings Call TranscriptApr 29, 2021ARS2502 (-0.71%)Earnings
- Merck & Co to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead Sciences Inc - Conference Call TranscriptMar 15, 2021
- Gilead Sciences Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Gilead Sciences Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2021ARS2550 (+1.39%)Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Galapagos NV & Gilead Sciences Inc to Announce New Commercialization and Development Agreement for Rheumatoid Arthritis Treatment Call TranscriptDec 16, 2020
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference TranscriptDec 02, 2020
- Q3 2020 Gilead Sciences Inc Earnings Call TranscriptOct 28, 2020ARS2340 (-6.40%)Earnings
- Gilead Sciences Inc to Acquire Immunomedics Inc Conference Call TranscriptSep 13, 2020
- Q2 2020 Gilead Sciences Inc Earnings Call TranscriptJul 30, 2020ARS2201.5 (+2.35%)Earnings
- Gilead Sciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2020
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 06, 2020
- Q1 2020 Gilead Sciences Inc Earnings Call TranscriptApr 30, 2020ARS2347 (-1.66%)Earnings
- Gilead Sciences Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Gilead Sciences Inc to Acquire Forty Seven Inc - Conference Call TranscriptMar 02, 2020
- Q4 2019 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2020Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Gilead Sciences Inc Earnings Call TranscriptOct 24, 2019Earnings
- Gilead Sciences Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Gilead Sciences Inc Earnings Call TranscriptJul 30, 2019Earnings
- Gilead Sciences Inc and Galapagos NV Enter Into Transformative Research and Development Collaboration Call TranscriptJul 14, 2019
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 05, 2019
- Gilead Sciences Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 08, 2019
- Q1 2019 Gilead Sciences Inc Earnings Call TranscriptMay 02, 2019Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2019Earnings
Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023 / 03:30PM GMT
Release Date Price:
ARS14125.5
(-0.83%)
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst
Thanks so much for joining us, everybody. Really pleased to be here hosting Gilead. Before we get started, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley, and we're very pleased to have Dan O'Day with us. Dan is Chairman and CEO; and Andy Dickinson, who is the company's CFO. But thank you both for taking time out of your day to join us today.
Daniel P. O;Day
Gilead Sciences, Inc. - Chairman & CEO
' -
Pleasure.
Questions & Answers
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst
I thought maybe we'd start off high level. Obviously, diversification has been a key part of the Gilead story and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)